MILS Trademark

Trademark Overview

On Thursday, August 4, 2016, a trademark application was filed for MILS with the United States Patent and Trademark Office. The USPTO has given the MILS trademark a serial number of 87127053. The federal status of this trademark filing is REGISTERED as of Tuesday, July 6, 2021. This trademark is owned by Windmil Therapeutics, Inc.. The MILS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

pharmaceutical research, drug discovery, and drug development services; medical and scientific research in the field of cancer and oncological disorders; research and development of pharmaceutical preparations for the prevention and treatment of cancer; development of new products for the prevention and treatment of cancer
mils

General Information

Serial Number87127053
Word MarkMILS
Filing DateThursday, August 4, 2016
Status700 - REGISTERED
Status DateTuesday, July 6, 2021
Registration Number6411495
Registration DateTuesday, July 6, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 17, 2018

Trademark Statements

Goods and Servicespharmaceutical research, drug discovery, and drug development services; medical and scientific research in the field of cancer and oncological disorders; research and development of pharmaceutical preparations for the prevention and treatment of cancer; development of new products for the prevention and treatment of cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 8, 2016
Primary Code042
First Use Anywhere DateMonday, December 9, 2019
First Use In Commerce DateMonday, December 9, 2019

Trademark Owner History

Party NameWindmil Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
US
Party NameWindmil Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
US
Party NameWindmil Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205
US

Trademark Events

Event DateEvent Description
Monday, August 8, 2016NEW APPLICATION ENTERED
Monday, August 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 16, 2016ASSIGNED TO EXAMINER
Wednesday, November 16, 2016NON-FINAL ACTION WRITTEN
Wednesday, November 16, 2016NON-FINAL ACTION E-MAILED
Wednesday, November 16, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 8, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 8, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 9, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 10, 2017FINAL REFUSAL WRITTEN
Monday, February 13, 2017FINAL REFUSAL WRITTEN
Monday, February 13, 2017FINAL REFUSAL WRITTEN
Monday, February 13, 2017FINAL REFUSAL E-MAILED
Monday, February 13, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, August 11, 2017EXPARTE APPEAL RECEIVED AT TTAB
Friday, August 11, 2017JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, August 11, 2017EX PARTE APPEAL-INSTITUTED
Friday, August 11, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, August 14, 2017ACTION CONTINUING FINAL - COMPLETED
Monday, August 14, 2017ACTION DENYING REQ FOR RECON E-MAILED
Monday, August 14, 2017NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Wednesday, March 7, 2018JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, March 12, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 12, 2018EXPARTE APPEAL TERMINATED
Wednesday, March 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 17, 2018PUBLISHED FOR OPPOSITION
Tuesday, April 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 12, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 10, 2018SOU TEAS EXTENSION RECEIVED
Monday, December 10, 2018SOU EXTENSION 1 FILED
Monday, December 10, 2018SOU EXTENSION 1 GRANTED
Wednesday, December 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 10, 2019SOU TEAS EXTENSION RECEIVED
Monday, June 10, 2019SOU EXTENSION 2 FILED
Monday, June 10, 2019SOU EXTENSION 2 GRANTED
Wednesday, June 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, December 3, 2019SOU EXTENSION 3 FILED
Tuesday, December 3, 2019SOU EXTENSION 3 GRANTED
Thursday, December 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 28, 2020SOU TEAS EXTENSION RECEIVED
Thursday, May 28, 2020SOU EXTENSION 4 FILED
Thursday, May 28, 2020SOU EXTENSION 4 GRANTED
Saturday, May 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 3, 2020SOU TEAS EXTENSION RECEIVED
Friday, December 4, 2020TEAS STATEMENT OF USE RECEIVED
Monday, December 14, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 4, 2020SOU EXTENSION 5 FILED
Wednesday, December 16, 2020SOU EXTENSION 5 GRANTED
Friday, December 4, 2020USE AMENDMENT FILED
Wednesday, December 16, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 16, 2020SU - NON-FINAL ACTION - WRITTEN
Wednesday, December 16, 2020NON-FINAL ACTION E-MAILED
Wednesday, December 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, February 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 27, 2021ASSIGNED TO LIE
Wednesday, June 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 3, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 4, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 6, 2021REGISTERED-PRINCIPAL REGISTER
Monday, July 6, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

mils cancer development research pharmaceutical prevention treatment drug products disorders preparations